Albertson B D, Frederick K L, Maronian N C, Feuillan P, Schorer S, Dunn J F, Loriaux D L
Developmental Endocrinology Branch, NICHD, NIH, Bethesda, Maryland 20892.
Res Commun Chem Pathol Pharmacol. 1988 Jul;61(1):17-26.
The in vitro inhibition of Leydig cell microsomal steroidogenesis by ketoconazole, a potent P-450 dependent enzyme blocker, was evaluated in the human, stallion and pig. Purified Leydig cells were isolated by mechanical dispersion of teased, decapsulated whole testes and sieving through a 0.25 mm stainless steel mesh. The activity of 3 beta-hydroxysteroid dehydrogenase/isomerase (3 beta-HSD), 17-hydroxylase (17-OHase), 17,20-desmolase (17,20D), 17-ketosteroid reductase (17-KSR) and aromatase were measured using a constant amount (50 microM) of 14C-labelled substrates in the presence of varying concentrations of pure ketoconazole. Products were isolated by thin layer chromatography and verified by derivative formation. 17-OHase and 17,20D activities were significantly inhibited (p less than .001) by ketoconazole at concentrations as low as 5 microM. 3 beta-HSD, 17-KSR and aromatase activities were only significantly inhibited by ketoconazole at concentrations of 500 and 5000 microM. These data describe the specific loci of inhibition of ketoconazole on testicular steroidogenesis and confirm the observations that ketoconazole is an effective inhibitor of androgen biosynthesis in several species.
在人类、种马和猪身上评估了酮康唑(一种强效的P - 450依赖性酶阻滞剂)对睾丸间质细胞微粒体类固醇生成的体外抑制作用。通过对 teased、去包膜的整个睾丸进行机械分散,并通过0.25毫米不锈钢筛网筛分来分离纯化的睾丸间质细胞。在存在不同浓度的纯酮康唑的情况下,使用恒定数量(50微摩尔)的14C标记底物测量3β - 羟类固醇脱氢酶/异构酶(3β - HSD)、17 - 羟化酶(17 - OHase)、17,20 - 裂解酶(17,20D)、17 - 酮类固醇还原酶(17 - KSR)和芳香化酶的活性。通过薄层色谱法分离产物并通过衍生物形成进行验证。酮康唑在低至5微摩尔的浓度下就可显著抑制(p小于0.001)17 - OHase和17,20D的活性。3β - HSD、17 - KSR和芳香化酶的活性仅在500和5000微摩尔的浓度下被酮康唑显著抑制。这些数据描述了酮康唑对睾丸类固醇生成抑制的特定位点,并证实了酮康唑是几种物种中雄激素生物合成的有效抑制剂这一观察结果。